In Treatment of Bacterial infections Synmega 250mg/125mg Tablet used to treat certain bacterial infections such as sinusitis (sinus infection), gonorrhea (a sexually transmitted disease), and infections of the ears, stomach, and urinary tract. It stops the growth of bacteria, thereby clearing the infection. This further reduces the discomforts associated with various infections and helps in early recovery. It is advisable to continue taking it as long as it is prescribed even when you feel better, to make sure that all bacteria are killed. Stopping it early may make the infection come back and difficult to treat.
Consuming alcohol with Synmega 250mg/125mg Tablet does not cause any harmful side effects.
Synmega 250mg/125mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Synmega 250mg/125mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
It is not known whether Synmega 250mg/125mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Synmega 250mg/125mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Synmega 250mg/125mg Tablet may be needed. Please consult your doctor.
There is limited information available on the use of Synmega 250mg/125mg Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Synmega 250mg/125mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Biochem Pharmaceutical Industries || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Astrum Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)